Phathom Pharmaceuticals

$38.49
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-0.18%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell PHAT and other stocks, options, and ETFs commission-free!

About PHAT

Phathom Pharmaceuticals, Inc. Common Stock, also called Phathom Pharmaceuticals, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases.

CEO
Terrie Curran
Employees
55
Headquarters
Florham Park, New Jersey
Founded
2018
Market Cap
1.19B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
104.47K
High Today
$39.38
Low Today
$37.32
Open Price
$38.83
Volume
54.63K
52 Week High
$64.54
52 Week Low
$27.47

PHAT Earnings

-$3.97
-$2.65
-$1.32
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 11, After Hours

You May Also Like

GMLP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure